Company: INSP
Filing Date: 2025-02-10
Form Type: 10-K
Source: 0001609550-25-000011
Chunk: 63

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-02-10
Form: 10-K
Item: Item 5
Chunk 63
---
Item 5.  Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock trades on the NYSE under the symbol “INSP."

Holders

As of February 3, 2025, there were approximately 12 holders of record of our common stock. This number does not include stockholders who are beneficial owners, but whose shares are held in street name by brokers and 

72

Table of Contents

other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.

Issuer Purchases of Equity Securities

Below is a summary of stock repurchases for the three months ended December 31, 2024. See Note 6 of our Notes to Consolidated Financial Statements for information regarding our stock repurchase program.

PeriodTotal number of shares purchasedAverage price paid per shareTotal number of shares purchased as part of publicly announced plans or programsApproximate dollar value of shares that may yet be repurchased under the plans or programs(1)October 1, 2024 - October 31, 2024— $— — $150,000,000 November 1, 2024 - November 30, 2024 (2)(2)(2)$75,000,000 December 1, 2024 - December 31, 2024— $— — $75,000,000 

(1) On August 6, 2024, our Board of Directors authorized the repurchase of up to $150.0 million in our common stock through August 5, 2026 in open market transactions, privately negotiated transactions, tender offers, or other means (the "Repurchase Program"). We are not obligated to repurchase any specific number of shares and the Repurchase Program may be modified, suspended, or discontinued at any time.

(2) In November 2024, we entered into an accelerated share repurchase agreement (the “ASR”) with a large financial institution as part of the Repurchase Program, whereupon we paid the counterparties to the ASR $75.0 million for the repurchase of shares of our common stock. In November 2024, we received an initial delivery of 305,157 shares of common stock representing a portion of the prepayment, which shares had an average price paid per share of $196.62. Upon final settlement of this ASR